Foreign body aspiration in children: a study of children who lived or died following aspiration - Mohammad M, Saleem M, Mahseeri M, Alabdallat I, Alomari A, Za'atreh A, Qudaisat I, Shudifat A, Nasri Alzoubi M.
Foreign body aspiration (FBA) is a preventable cause of mortality and morbidity in children. We conducted a chart review of children who presented to a university hospital due to FBA in the period 1999-2014. Children were either managed with bronchoscopy f... (Source: SafetyLit)
Source: SafetyLit - June 8, 2017 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
MassDevice.com +5 | The top 5 medtech stories for May 24, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Feds charge ex-Medicare employees with insider trading
Former employees at the Centers for Medicare & Medicaid Services used confidential information on Medicare reimbursement changes for radiation treatments and dialysis i...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Boston Scientific ’ s post-approval Alair study shows long-term asthma improvement
Patients treated with the Alair device made by Boston Scientific (NYSE:BSX) showed long-term improvement in controlling their asthma, according to a post-approval study released today at the annual meeting of the American Thoracic Society in Washington.
The Alair bronchial thermoplasty treatment uses a bronchoscope to deliver radiofrequency energy to reduce the amount of excess smooth muscle tissue in the airways. Boston acquired the technology when it paid $194 million in cash for Asthmatx in 2010, shortly after that company won 510(k) clearance from the FDA for Alair. The deal also included some $250 million in potentia...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Respiratory Wall Street Beat Boston Scientific Source Type: news
7 medtech stories we missed this week: May 19, 2017
[Image from unsplash.com]From FDA clearances to touting study data, here are 7 medtech stories we missed this week but thought were still worth mentioning.
1. XpandOrtho wins FDA 510(k) clearance
XpandOrtho announced in a May 17 press release that it has received FDA 510(k) clearance for its electronic soft tissue balancing instrument for total knee replacement surgery. The sterile-packaged wireless disposable device uses miniature sensors and actuators to balance knee joints during full-range motions. Using constant pressure bellows systems, the device communicates with a display for multiaxial balance and selection of th...
Source: Mass Device - May 19, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Clinical Trials Food & Drug Administration (FDA) Regulatory/Compliance Research & Development Body Vision Medical Exactech Inc. Lombard Medical Technologies MedTech NxThera Inc. Rivanna Medical Visionsense XpandOrtho Source Type: news
Dentistry researcher receives a $2.5M grant to validate liquid biopsy test for lung cancer
In an effort to move the needle forward to improve cancer detection techniques, the National Cancer Institute awarded $2.5 million over a period of five years to principal investigator,Dr. David Wong, a professor of oral biology and associate dean for research at the UCLA School of Dentistry. The grant will support a clinical trial to validate the research team’s liquid biopsy test, a rapidly emerging technology, with the goal to have it become a certified service at UCLA and beyond.For this project, the dental school is partnering with the UCLA Department of Pathology and Lab Medicine, led by Dr. Scott Binder, senior ...
Source: UCLA Newsroom: Health Sciences - March 30, 2017 Category: Universities & Medical Training Source Type: news
Dilatational Tracheotomy Using the Rigid Endoscope Dilatational Tracheotomy Using the Rigid Endoscope
Is the use of a rigid tracheotomy endoscope a feasible alternative to fiberoptic tracheo-bronchoscopy for dilational tracheotomy?BMC Anesthesiology (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - March 22, 2017 Category: Intensive Care Tags: Anesthesiology Journal Article Source Type: news
Network Modeling Could Optimize End-Stage Emphysema Tx
(MedPage Today) -- Model suggests similar outcomes with surgical, bronchoscopic lung volume reduction (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - February 10, 2017 Category: Respiratory Medicine Source Type: news
Single-use bronchoscopes appear cost effective in USA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - January 31, 2017 Category: Drugs & Pharmacology Source Type: news
My Macgyver Moment
Since emergency physicians are the MacGyvers of medicine – mullet not included – we asked our readers to send in their best stories of improvising on the fly. What did you do when you were fighting against the clock and couldn’t find the supplies you needed? Here are our four winning entries, with comments by Ken Iserson, MD, author of Improvised Medicine.
Published entrants gain free admittance to Blood and Sand, a tropical CME in Atlantis, Bahamas. For a chance to win, send your best MacGyver Moment to
lplaster@epmonthly.com
Give Me a Hand(stand)
by Andrew Langsam
I was getting ready to go on a long-a...
Source: EPMonthly.com - December 31, 2016 Category: Emergency Medicine Authors: Matt McGahen Tags: Uncategorized Source Type: news
Creo Medical looks to raise $25m in UK IPO
U.K.-based electrosurgery device developer Creo Medical said today it looks to raise $25.3 million (UK £20 million) in a U.K. initial public offering, expected to take place on December 9.
Creo Medical said it plans to offer shares at approximately 97¢ per share (UK £0.79), while the company has an estimated market capitalization of approximately $77.7 million (UK £61.3 million).
The company is developing minimally invasive surgical devices, initially focused on gastrointestinal surgery and lung cancer, using the company’s Croma system which combines bipolar radiofrequency and microwave energy technology.
Creo M...
Source: Mass Device - December 6, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Initial Public Offering (IPO) Surgical Creo Medical Source Type: news
MassDevice.com +5 | The top 5 medtech stories for November 8, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Stanford uses CRISPR to correct sickle cell, human trials planned
Researchers from the Stanford University School of Medicine have reportedly used CRISPR, a gene-editing tool, to repair the gene that causes sickle cell disease....
Source: Mass Device - November 8, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Positive 1-month safety results for Medtronic ’ s Navigate bronchoscopy trial
Medtronic (NYSE:MDT) today released 1-month data from the Navigate trial of its superDimension LungGPS system, touting the device as safe and effective based on the preliminary results.
A total of 1,289 patients have been enrolled in the trial to date, which spans 37 sites across Europe and North America. The trial looks to evaluate the performance of Fridley, Minn.-based Medtronic’s LungGPS electromagnetic navigation bronchoscopy technology the SuperDimension device uses to navigate the lungs.
The initial data comes from 500 procedures, 497 of which were lung lesion biopsies, 91 for fiducial placement and 9 for dye ...
Source: Mass Device - November 8, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Imaging Respiratory Medtronic Source Type: news
First Glimpse of NAVIGATE Bronchoscopy Results Is Promising First Glimpse of NAVIGATE Bronchoscopy Results Is Promising
Interim results from the more than 1200 patient NAVIGATE trial in North America and Europe suggest that electromagnetic navigation bronchoscopy can be safely used to evaluate lung lesions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2016 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
My Macgyver Moment
Since emergency physicians are the MacGyvers of medicine – mullet not included – we asked our readers to send in their best stories of improvising on the fly. What did you do when you were fighting against the clock and couldn’t find the supplies you needed? Here are our four winning entries, with comments by Ken Iserson, MD, author of Improvised Medicine.
Published entrants gain free admittance to Blood and Sand, a tropical CME in Atlantis, Bahamas. For a chance to win, send your best MacGyver Moment to
lplaster@epmonthly.com
Give Me a Hand(stand)
by Andrew Langsam
I was getting ready to go on a long-awaited d...
Source: EPMonthly.com - September 19, 2016 Category: Emergency Medicine Authors: Matt McGahen Tags: Uncategorized Source Type: news
